UNCY Stock Analysis: Buy, Sell, or Hold?
UNCY - Unicycive Therapeutics, Inc. Common Stock
$5.06
0.04 (0.90%)
▲
5d:
-1.46%
30d:
-11.78%
90d:
-34.09%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When UNCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: UNCY trading at deep discount. Market pricing in -2.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: UNCY trading at deep discount. Market pricing in -2.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.93
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UNCY is currently trading at $5.05, which is considered slightly low relative to its 30-day fair value range of $4.73 to $6.92. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.0) compared to its historical average (1.1). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, UNCY is in a downtrend. Immediate support is located at $4.71, while resistance sits at $5.87.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.59 (+663.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UNCY is in a downtrend. Immediate support is located at $4.71, while resistance sits at $5.87.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $38.59 (+663.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.73 -
$6.92
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 663.4% below Wall St target ($38.59)
Trading Range Analysis
30-Day Trading Range
$4.73 -
$6.92
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.71
Resistance Level
$5.87
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.98
Wall Street Target
$38.59
(+663.4%)
Valuation Discount vs History
-2.6% cheaper
PE vs Historical
1.0 vs 1.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.6%
(market-implied from PE analysis)
1-Year Target
$4.92
(-3%)
2-Year Target
$4.80
(-5%)
3-Year Target
$4.67
(-8%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
$5.23
(+4%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.0 to 1.1
Stabilization Target:
$5.66
(+12.0%)
PE Expansion Potential:
+12.0%
Share & Embed Analysis
Last updated: August 04, 2026 1:09 AM ET
Data refreshes hourly during market hours. Next update: 2:09 AM
Data refreshes hourly during market hours. Next update: 2:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UNCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 46 HOLD |
